Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2021-12-09
2022-06-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Progressive Lens Designs
NCT04734522
Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle
NCT01234207
Clinical Evaluation of a Progressive Addition Lens (PAL)
NCT01443585
Multifocal Visual Performance Study
NCT03757039
Comparison of Aspheric Toric & Non-toric Aphakic Intraocular Lenses
NCT01268540
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental: The specified PAL design wearers
Subjects who have been already wearing any from specified design type of PAL
Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating
Subjects will be wearing three different PAL designs with different geometries of the optical progression.
The other PAL design wearers
Subjects who have been already wearing any from the other design type of PAL
Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating
Subjects will be wearing three different PAL designs with different geometries of the optical progression.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating
Subjects will be wearing three different PAL designs with different geometries of the optical progression.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Visual Acuity: far \& near monocular: cc ≥ 20/20 (decimal cc ≥ 1.0)
* Normal binocular vision (at distance \& near: no strabismus on cover testing, aligning prism of less than 2Δ horizontally or vertically, stereoacuity of 2' or better at distance and near).
* Prescription is in the range:
* Spherical power: less than +/-6.00 D
* Cylindrical power: less than -2.75 D
* Addition: 1.50 D - 2.50 D
* Difference in power (spherical equivalent) between eyes: less than 2.00 D
Exclusion Criteria
* First prescription for progressive lenses.
* Prescription found during visit#1 varies from current prescription more than 0.50 D in any meridian.
* Currently wearing single vision lenses with accommodative support.
* Double vision or prismatic prescription in current glasses.
* Known ocular disease including strabismus, any pathology, any eye surgeries that may affect visual acuity.
* Use of systemic or ocular medications that are likely to affect vision.
* Balance problem/vertigo problem.
* Concurrent participation in other vision-related research.
45 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoya Vision Care
INDUSTRY
Western University of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frank Spors, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Western University of Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Western University of Health Sciences
Pomona, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P21/IRB/065
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.